L-Proline,N-(cyclohexylcarbonyl)-D-alanyl-(2S)-3-mercapto-2-methylpropanoyl-, calciumsalt (2:1) cas no:85921-53-5

NameL-Proline,N-(cyclohexylcarbonyl)-D-alanyl-(2S)-3-mercapto-2-methylpropanoyl-, calciumsalt (2:1)
CAS85921-53-5
SynonymsL-Proline,1-[3-[[2-[(cyclohexylcarbonyl)amino]-1-oxopropyl]thio]-2-methyl-1-oxopropyl]-,calcium salt (2:1), [R-(R*,S*)]-; Altiopril calcium; L-Proline,1-[(2S)-3-[[(2R)-2-[(cyclohexylcarbonyl)amino]-1-oxopropyl]thio]-2-methyl-1-oxopropyl]-,calcium salt (2:1); Lowpres; MC 838; Moveltipril calcium
Molecular FormulaC19H30 N2 O5 S . 1/2 Ca
Molecular Weight835.10

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
dog	LD50	oral	> 6gm/kg (6000mg/kg)		Tohoku Journal of Experimental Medicine. Vol. 152, Pg. 363, 1987.
mouse	LD50	intraperitoneal	2100mg/kg (2100mg/kg)		Tohoku Journal of Experimental Medicine. Vol. 152, Pg. 363, 1987.
mouse	LD50	oral	> 10gm/kg (10000mg/kg)		Tohoku Journal of Experimental Medicine. Vol. 152, Pg. 363, 1987.
mouse	LD50	subcutaneous	3gm/kg (3000mg/kg)		Tohoku Journal of Experimental Medicine. Vol. 152, Pg. 363, 1987.
rat	LD50	intraperitoneal	1300mg/kg (1300mg/kg)		Tohoku Journal of Experimental Medicine. Vol. 152, Pg. 363, 1987.
rat	LD50	oral	> 10gm/kg (10000mg/kg)		Tohoku Journal of Experimental Medicine. Vol. 152, Pg. 363, 1987.
rat	LD50	subcutaneous	3400mg/kg (3400mg/kg)		Tohoku Journal of Experimental Medicine. Vol. 152, Pg. 363, 1987.